Marat Fudim, MD MHS
@fudimmarat
Duke Cardiology, 🇺🇦+🇩🇪+🇺🇸, #HeartFailure. Views expressed are my own and do not reflect the views or opinions of my employer.
ID: 716472149213634560
03-04-2016 03:47:26
3,3K Tweet
4,4K Takipçi
1,1K Takip Edilen
Finerenone meets primary endpoint in Phase III FINEARTS-HF🎉 ❤️ expanded treatment options for HFpEF! —> to be presented at ESC ‼️pending: the SPIRRT HFPEF trial with MRA Duke Clinical Research Institute Karolinska Institutet Uppsala University NIH NHLBI bayer.com/media/en-us/fi…